Encompass Health Corp Stock Alpha and Beta Analysis

EHC Stock  USD 95.98  2.30  2.46%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Encompass Health Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Encompass Health over a specified time horizon. Remember, high Encompass Health's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Encompass Health's market risk premium analysis include:
Beta
0.63
Alpha
(0.05)
Risk
1.3
Sharpe Ratio
(0.05)
Expected Return
(0.06)
Please note that although Encompass Health alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Encompass Health did 0.05  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Encompass Health Corp stock's relative risk over its benchmark. Encompass Health Corp has a beta of 0.63  . As returns on the market increase, Encompass Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Encompass Health is expected to be smaller as well. The current year's Book Value Per Share is expected to grow to 29.95. The current year's Tangible Book Value Per Share is expected to grow to 13.32.

Encompass Health Quarterly Cash And Equivalents

99.7 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Encompass Health Backtesting, Encompass Health Valuation, Encompass Health Correlation, Encompass Health Hype Analysis, Encompass Health Volatility, Encompass Health History and analyze Encompass Health Performance.

Encompass Health Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Encompass Health market risk premium is the additional return an investor will receive from holding Encompass Health long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Encompass Health. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Encompass Health's performance over market.
α-0.05   β0.63

Encompass Health expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Encompass Health's Buy-and-hold return. Our buy-and-hold chart shows how Encompass Health performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Encompass Health Market Price Analysis

Market price analysis indicators help investors to evaluate how Encompass Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Encompass Health shares will generate the highest return on investment. By understating and applying Encompass Health stock market price indicators, traders can identify Encompass Health position entry and exit signals to maximize returns.

Encompass Health Return and Market Media

The median price of Encompass Health for the period between Sat, Dec 14, 2024 and Fri, Mar 14, 2025 is 98.01 with a coefficient of variation of 3.48. The daily time series for the period is distributed with a sample standard deviation of 3.38, arithmetic mean of 97.1, and mean deviation of 2.98. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Disposition of 2446 shares by Andrew Price of Encompass Health at 92.35 subject to Rule 16b-3
12/31/2024
2
Reinhart Partners LLC. Has 60.61 Million Stake in Encompass Health Co. - MarketBeat
01/13/2025
 
Encompass Health dividend paid on 15th of January 2025
01/15/2025
3
Acquisition by Christie Edward M Iii of 292 shares of Encompass Health at 94.4 subject to Rule 16b-3
01/16/2025
4
Encompass Health Named One of Fortunes Worlds Most Admired Companies for Fifth Consecutive Year
02/05/2025
5
Encompass Health Q4 Earnings Beat on Strong Discharge Growth
02/11/2025
6
Encompass Health opens new hospital in Georgia
02/19/2025
7
Encompass Health Declares US0.17 Quarterly Dividend Payable April 15 2025
02/20/2025
8
Encompass Health Corp Declares Quarterly Dividend
02/21/2025
9
Disposition of 401 shares by Andrew Price of Encompass Health at 97.53 subject to Rule 16b-3
02/24/2025
10
Disposition of 410 shares by Andrew Price of Encompass Health at 100.63 subject to Rule 16b-3
02/25/2025
11
Are You a Value Investor This 1 Stock Could Be the Perfect Pick
02/26/2025
12
Disposition of 304 shares by Andrew Price of Encompass Health at 100.14 subject to Rule 16b-3
02/28/2025
13
Encompass Health Full Year 2024 Earnings EPS Beats Expectations
03/04/2025
14
Disposition of 416 shares by John Darby of Encompass Health at 100.14 subject to Rule 16b-3
03/06/2025
15
Raymond James Financial Inc. Acquires New Holdings in Encompass Health Co.
03/10/2025

About Encompass Health Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Encompass or other stocks. Alpha measures the amount that position in Encompass Health Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2022 2023 2024 2025 (projected)
Dividend Yield0.01670.0090980.0068070.006467
Price To Sales Ratio1.361.381.722.49

Encompass Health Upcoming Company Events

As portrayed in its financial statements, the presentation of Encompass Health's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Encompass Health's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Encompass Health's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Encompass Health. Please utilize our Beneish M Score to check the likelihood of Encompass Health's management manipulating its earnings.
7th of February 2024
Upcoming Quarterly Report
View
25th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
7th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Encompass Health

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Encompass Health Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Encompass Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Encompass Health Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Encompass Health Corp Stock:
Encompass Health technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Encompass Health technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Encompass Health trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...